Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Loss
Beginning balances (in shares) at Dec. 31, 2022		286,851,595
Beginning balances at Dec. 31, 2022	$ 1,233,277	$ 734,365	$ 74,118	$ 426,185	$ (1,391)
Number of Shares
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		1,574,919
Shares issued and restricted stock units ("RSUs") vested under stock option plan	489	$ 8,451	(7,962)
Share-based compensation expense	15,474		15,474
Foreign currency translation adjustment	(630)				(630)
Net loss	(40,110)			(40,110)
Ending balances (in shares) at Mar. 31, 2023		288,426,514
Ending balances at Mar. 31, 2023	1,208,500	$ 742,816	81,630	386,075	(2,021)
Beginning balances (in shares) at Dec. 31, 2023		290,824,970
Beginning balances at Dec. 31, 2023	1,152,318	$ 753,199	121,052	279,787	(1,720)
Number of Shares
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		2,796,342
Shares issued and restricted stock units ("RSUs") vested under stock option plan	892	$ 11,363	(10,471)
Share-based compensation expense	17,409		17,409
Foreign currency translation adjustment	(96)				(96)
Net loss	(40,610)			(40,610)
Ending balances (in shares) at Mar. 31, 2024		293,621,312
Ending balances at Mar. 31, 2024	$ 1,129,913	$ 764,562	$ 127,990	$ 239,177	$ (1,816)